MENU

KROS Keros Therapeutics Forecast, Technical & Fundamental Analysis

a biopharmaceutical company, which focuses on treatments for rare muscle diseases

Industry Biotechnology
KROS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
KROS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

KROS is expected to report earnings to -125 cents per share on October 31

Keros Therapeutics KROS Stock Earnings Reports
Q3'24
Est.
$-1.26
Q2'24
Beat
by $0.01
Q1'24
Beat
by $0.12
Q4'23
Beat
by $0.03
Q3'23
Beat
by $0.02
The last earnings report on August 07 showed earnings per share of -125 cents, beating the estimate of -125 cents. With 291.00K shares outstanding, the current market capitalization sits at 2.12B.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which focuses on treatments for rare muscle diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1050 Waltham Street
Phone
+1 617 314-6297
Employees
136
Web
https://www.kerostx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME23.14-0.28
-1.20%
GameStop Corp
TSLA210.60-3.51
-1.64%
Tesla
SPY552.08-11.60
-2.06%
SPDR® S&P 500® ETF Trust
AAPL222.77-6.23
-2.72%
Apple
BTC.X57431.023000-1681.457000
-2.84%
Bitcoin cryptocurrency

KROS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, KROS has been loosely correlated with KYMR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if KROS jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KROS
1D Price
Change %
KROS100%
+5.38%
KYMR - KROS
49%
Loosely correlated
-4.22%
XNCR - KROS
48%
Loosely correlated
-3.14%
ATAI - KROS
46%
Loosely correlated
-6.15%
VRDN - KROS
45%
Loosely correlated
-1.43%
COGT - KROS
45%
Loosely correlated
+1.96%
More